GSK vs NOG · P/E 13, $103.31B cap vs rev $750.3M
GlaxoSmithKline PLC ADR (GSK) versus Northern Oil & Gas Inc (NOG) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Northern Oil & Gas Inc (NOG) is a oil & gas e&p company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported NOG revenue for 2026-06-30 was $750.3M. Net income was -$286.2M. NOG currently screens at market cap $2.10B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. NOG currently screens at market cap $2.10B.
Not investment advice. Open the GSK and NOG stock pages for the full models.
Not investment advice.